Status:
COMPLETED
Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA)
Lead Sponsor:
Royal Cornwall Hospitals Trust
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18-19 years
Brief Summary
Rapid On-Site Evaluation (ROSE) of cytology FNA samples performed by a Pathologist or Biomedical Scientist is a real time morphological assessment of the sample in the clinical setting with the aim of...
Detailed Description
The new faster diagnostic standards (FDS) alongside NICE guidance and the British association of Head and Neck Oncologists (BAHNO) guidelines, state that ROSE should be provided for all FNA's. It is n...
Eligibility Criteria
Inclusion
- Male and female participants \> 18-90 years of age
- Participants attending for an ultrasound guided fine needle aspiration of lesions in the head and neck and supraclavicular fossa nodes.
- All ethnicity or socioeconomic grouping that require an US FNA at RCHT over the 12-month study period.
- Able and willing to consent to the study
Exclusion
- Anyone \<18 years of age
- Patients that do not require an FNA after the initial ultrasound
- Any participants considered vulnerable will not be included in the study.
- This study involves testing the concept of remote ROSE rather than direct impact on patient care needs related to ethical of communication issues. For practical considerations and to prevent unnecessary anxiety for patients who are unable to read the information sheets and provide consent, these patients will not be included in the study.
- Unable or unwilling to consent to the study
Key Trial Info
Start Date :
October 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 24 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05962944
Start Date
October 25 2022
End Date
July 24 2023
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Cornwall Hospital
Truro, Cornwall, United Kingdom, TR1 3LJ